×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
European Lung Cancer Congress 2022
Final Programme PDF
Advanced Search
30.03.2022
31.03.2022
01.04.2022
02.04.2022
Controversy session
Educational session
Industry Satellite Symposium
Keynote lecture
Mini Oral session
Special Symposium
Special session
Young oncologists session
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
Congress Hall
15:10(1h 30m)
EGFR, Exon 20 and ALK
09:30(30m)
Lung cancer in 2030
08:15(1h)
Mini Oral session 2
10:30(1h 30m)
New roads in I-O
17:00(1h 30m)
Oncogene addicted tumours, KRAS, RET, HER2, BRAF
14:30(30m)
Value of pathological response as an endpoint
Forum Hall
12:45(1h 30m)
AstraZeneca - Unresectable stage III NSCLC: No patients left behind
17:00(1h 30m)
Covid 19, vaccines and management of patients outside the pandemic
15:10(1h 30m)
How to tackle synchronous oligometastases
10:30(1h 30m)
Perioperative strategies: ICI, TKIs, adjuvant, neoadjuvant
18:45(1h 30m)
Sanofi Genzyme - Quantity versus quality of life in advanced NSCLC patients treated with immunotherapy
08:15(1h)
Sublobar resection versus lobectomy
South Hall 2
10:30(1h 30m)
How to use real-world evidence for clinical decision making
15:10(1h 30m)
Long terms responders
18:45(1h 30m)
MSD - Evolving immuno-oncology treatment paradigm in NSCLC
12:45(1h 30m)
Novocure - TTFields: A potential innovative treatment modality in lung cancer
17:00(1h 30m)
Scientific advances in malignant pleural mesothelioma
08:15(1h)
YO session 2
Club A
08:30(1h 30m)
EONS session 1
10:30(1h 30m)
EONS session 2
12:45(1h 30m)
LuCE session 1
15:10(1h 30m)
LuCE session 2
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events